Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Eltrombopag for Inherited Thrombocytopenias
NCT02422394Phase 2Completed
- Sponsor
- IRCCS San Matteo Foundation
- Start
- Apr 2015
- Primary completion
- Mar 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of eltrombopag in inherited thrombocytopenia, sponsored by IRCCS San Matteo Foundation. Started Apr 2015; status: completed.
02
Drugs
eltrombopag
03
Conditions
inherited thrombocytopenia
Beyond the preview
Go deeper on NCT02422394.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02422394.